AbbVie wins reversal of $140 million verdict in case over AndroGel risks

A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.

Source: Reuters: Health - July 6, 2018 Category: Consumer Health News Tags: healthNews Source Type: news